The protective role of Smad7 in diabetic kidney disease: Mechanism and therapeutic potential

Hai Yong Chen, Xiao R Huang, Wansheng Wang, Jinhua Li, Rainer L Heuchel, Arthur CK Chung, Hui Yao Lan

Research output: Contribution to journalArticleResearchpeer-review

165 Citations (Scopus)

Abstract

Although Smad3 has been considered as a downstream mediator of transforming growth factor-beta (TGF-beta) signaling in diabetes complications, the role of Smad7 in diabetes remains largely unclear. The current study tests the hypothesis that Smad7 may play a protective role and has therapeutic potential for diabetic kidney disease. RESEARCH DESIGN AND METHODS Protective role of Smad7 in diabetic kidney disease was examined in streptozotocin-induced diabetic mice that have Smad7 gene knockout (KO) and in diabetic rats given Smad7 gene transfer using an ultrasound-microbubble-mediated technique. RESULTS We found that mice deficient for Smad7 developed more severe diabetic kidney injury than wild-type mice as evidenced by a significant increase in microalbuminuria, renal fibrosis (collagen I, IV, and fibronectin), and renal inflammation (interleukin-1beta [IL-1beta], tumor necrosis factor-alpha [TNF-alpha], monocyte chemoattractant protein-1 [MCP-1], intracellular adhesion molecule-1 [ICAM-1], and macrophages). Further studies revealed that enhanced renal fibrosis and inflammation in Smad7 KO mice with diabetes were associated with increased activation of both TGF-beta/Smad2/3 and nuclear factor-kappaB (NF-kappaB) signaling pathways. To develop a therapeutic potential for diabetic kidney disease, Smad7 gene was transferred into the kidney in diabetic rats by an ultrasound-microbubble-mediated technique. Although overexpression of renal Smad7 had no effect on levels of blood glucose, it significantly attenuated the development of microalbuminuria, TGF-beta/Smad3-mediated renal fibrosis such as collagen I and IV and fibronectin accumulation and NF-kappaB/p65-driven renal inflammation including IL-1beta, TNF-alpha, MCP-1, and ICAM-1 expression and macrophage infiltration in diabetic rats. CONCLUSIONS Smad7 plays a protective role in diabetic renal injury. Overexpression of Smad7 may represent a novel therapy for the diabetic kidney complication.
Original languageEnglish
Pages (from-to)590 - 601
Number of pages12
JournalDiabetes
Volume60
Issue number2
DOIs
Publication statusPublished - 2011

Cite this

Chen, H. Y., Huang, X. R., Wang, W., Li, J., Heuchel, R. L., Chung, A. CK., & Lan, H. Y. (2011). The protective role of Smad7 in diabetic kidney disease: Mechanism and therapeutic potential. Diabetes, 60(2), 590 - 601. https://doi.org/10.2337/db10-0403